Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia.
Fabio EfficaceFrancesco CottoneBetina YanezVamsi K KotaFausto CastagnettiGiovanni CaocciMassimiliano BonifacioAndrea PatriarcaIsabella CapodannoMaria Cristina MiggianoMario TiribelliMassimo BrecciaLuigia LucianoValentina GiaiAlessandra IurloElisabetta AbruzzeseCarmen FavaShira DinnerJessica K AltmanGianantonio RostiJorge CortesMarco VignettiDavid CellaPublished in: Cancer (2023)
Patient-reported symptom monitoring from the beginning of therapy in patients with CML may be critical to improve adherence to therapy and early molecular response rates (ClinicalTrials.gov identifier NCT04384848).